NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDLiraglutide Saxenda®
(6mg/ml Solution for injection in pre-filled pen) 		Central nervous system, Drugs used in the treatment of obesity, 04.05
 Liraglutide  Endocrine system, GLP-1 mimetics, 06.01.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Insulin  Insulin Degludec With Liraglutide Endocrine System, Insulins, Insulins, Long-Acting
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Liraglutide Liraglutide Endocrine System, Blood Glucose Lowering Drugs, Glucagon-Like Peptide-1 Receptor Agonists
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Liraglutide Liraglutide Gastro-Intestinal System, Blood Glucose Lowering Drugs, Glucagon-Like Peptide-1 Receptor Agonists
Obesity
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Guidance for General Practitioners to support prescribing of Liraglutide for children and young people under 18 years with Type 2 Diabetes (T2DM) – BLMKICB Medicines Optimisation
MHRA DSU Nov 2023 Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products
NICE TA 664 Liraglutide for managing overweight and obesity